10x Genomics (TXG) News Today → Executive Order To Wipe Out Your Bank Accounts (From Oasis Gold) (Ad) Free TXG Stock Alerts $21.49 -0.38 (-1.74%) (As of 09:45 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 6, 2024 | marketbeat.comArmistice Capital LLC Makes New Investment in 10x Genomics, Inc. (NASDAQ:TXG)Armistice Capital LLC bought a new position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 92,000 shares of the company's stock, valued at approximately $5,148,000.June 4, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Reaches New 12-Month Low at $21.2910x Genomics (NASDAQ:TXG) Sets New 1-Year Low at $21.29June 3, 2024 | marketbeat.comSands Capital Management LLC Sells 395,325 Shares of 10x Genomics, Inc. (NASDAQ:TXG)Sands Capital Management LLC reduced its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 9.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,590,145 shares of the company's stock after selling 395,325 sharesJune 3, 2024 | americanbankingnews.com10x Genomics (NASDAQ:TXG) Now Covered by Jefferies Financial GroupMay 31, 2024 | marketbeat.com647,996 Shares in 10x Genomics, Inc. (NASDAQ:TXG) Bought by Norges BankNorges Bank purchased a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 647,996 shares of the company's stock, valued at approximaMay 30, 2024 | marketbeat.comDecheng Capital LLC Takes $20.12 Million Position in 10x Genomics, Inc. (NASDAQ:TXG)Decheng Capital LLC bought a new stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 359,554 shares of the company's stock, valued at approximately $2May 29, 2024 | prnewswire.com10x Genomics Launches 5,000-Plex Gene Panel for XeniumMay 28, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Hits New 1-Year Low at $22.2410x Genomics (NASDAQ:TXG) Hits New 52-Week Low at $22.24May 28, 2024 | markets.businessinsider.comCathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKFMay 27, 2024 | marketbeat.com10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Franklin Resources Inc.Franklin Resources Inc. decreased its holdings in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 15.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 527,577 shares of the company's sMay 24, 2024 | insidertrades.com10x Genomics, Inc. (NASDAQ:TXG) CFO Justin J. Mcanear Sells 2,936 SharesMay 23, 2024 | marketbeat.com10x Genomics, Inc. (NASDAQ:TXG) CFO Sells $71,344.80 in Stock10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) CFO Justin J. Mcanear sold 2,936 shares of 10x Genomics stock in a transaction on Wednesday, May 22nd. The stock was sold at an average price of $24.30, for a total value of $71,344.80. Following the sale, the chief financial officer now directly owns 146,203 shares of the company's stock, valued at approximately $3,552,732.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.May 21, 2024 | marketbeat.comAssenagon Asset Management S.A. Grows Position in 10x Genomics, Inc. (NASDAQ:TXG)Assenagon Asset Management S.A. increased its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 260.5% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 63,400 shares of the company's stock after acquiring an aMay 20, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Sets New 12-Month Low at $24.5210x Genomics (NASDAQ:TXG) Sets New 1-Year Low at $24.52May 18, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Buys 32,709 Shares of 10x Genomics, Inc. (NASDAQ:TXG)Charles Schwab Investment Management Inc. lifted its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 3.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 924,832 shares of the company's stock after acquMay 17, 2024 | marketbeat.comNikko Asset Management Americas Inc. Has $127.76 Million Stock Position in 10x Genomics, Inc. (NASDAQ:TXG)Nikko Asset Management Americas Inc. increased its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 32.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,283,530 shares of the comMay 15, 2024 | marketbeat.comJump Financial LLC Decreases Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)Jump Financial LLC lowered its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 56.9% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 31,803 shares of the company's stock after selling 42,052 shares during the period. Jump Financial LLC'sMay 14, 2024 | finance.yahoo.comCathie Wood’s Latest Buys: 3 Stocks the ARK Invest CEO Can’t Get Enough OfMay 6, 2024 | investorplace.comCathie Wood's Latest Buys: 3 Stocks the ARK Invest CEO Can't Get Enough OfMay 4, 2024 | marketbeat.comVestmark Advisory Solutions Inc. Makes New $4.33 Million Investment in 10x Genomics, Inc. (NASDAQ:TXG)Vestmark Advisory Solutions Inc. bought a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 77,409 shares of the company's stock, valued at approximately $4,332,000. VeMay 3, 2024 | marketbeat.comQ2 2024 Earnings Estimate for 10x Genomics, Inc. Issued By William Blair (NASDAQ:TXG)10x Genomics, Inc. (NASDAQ:TXG - Free Report) - William Blair lifted their Q2 2024 EPS estimates for 10x Genomics in a note issued to investors on Wednesday, May 1st. William Blair analyst M. Larew now anticipates that the company will post earnings per share of ($0.53) for the quarter, up from tMay 2, 2024 | prnewswire.com10x Genomics to Present at the BofA Securities 2024 Healthcare ConferenceMay 2, 2024 | msn.comTD Cowen Downgrades 10x Genomics (TXG)May 2, 2024 | finance.yahoo.com10x Genomics First Quarter 2024 Earnings: In Line With ExpectationsMay 2, 2024 | finanznachrichten.de10x Genomics, Inc: 10x Genomics Reports First Quarter 2024 Financial ResultsMay 1, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Given New $30.00 Price Target at UBS GroupUBS Group lowered their target price on shares of 10x Genomics from $52.00 to $30.00 and set a "neutral" rating on the stock in a research report on Wednesday.May 1, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Hits New 12-Month Low After Analyst Downgrade10x Genomics (NASDAQ:TXG) Reaches New 1-Year Low After Analyst DowngradeMay 1, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: 10x Genomics (TXG), Zoetis (ZTS) and Blueprint Medicines (BPMC)May 1, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Downgraded by TD CowenTD Cowen downgraded 10x Genomics from a "buy" rating to a "hold" rating and dropped their price objective for the company from $57.00 to $32.00 in a research note on Wednesday.May 1, 2024 | finance.yahoo.com10x Genomics Inc (TXG) (Q1 2024) Earnings Call Transcript Highlights: Diverse Revenue Streams ...May 1, 2024 | businesswire.comCurio Bioscience Reports Clarifying Decision From European Unified Patent Court (UPC)April 30, 2024 | sfgate.com10x Genomics: Q1 Earnings SnapshotApril 30, 2024 | markets.businessinsider.comTXG Stock Earnings: 10x Genomics Meets EPS, Misses Revenue for Q1 2024April 30, 2024 | finance.yahoo.com10x Genomics Inc (TXG) Q1 2024 Earnings: Misses Analyst Expectations Amidst New Product LaunchesApril 30, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Releases Earnings Results, Misses Estimates By $0.04 EPS10x Genomics (NASDAQ:TXG - Get Free Report) announced its earnings results on Tuesday. The company reported ($0.50) EPS for the quarter, missing the consensus estimate of ($0.46) by ($0.04). 10x Genomics had a negative return on equity of 28.82% and a negative net margin of 41.17%. The company had revenue of $141.01 million for the quarter, compared to analyst estimates of $142.24 million. During the same period in the previous year, the firm posted ($0.44) earnings per share. The firm's quarterly revenue was up 5.0% compared to the same quarter last year.April 30, 2024 | prnewswire.com10x Genomics Reports First Quarter 2024 Financial ResultsApril 29, 2024 | markets.businessinsider.com10x Genomics A is about to announce its earnings — here's what Wall Street expectsApril 29, 2024 | marketbeat.comCanaccord Genuity Group Cuts 10x Genomics (NASDAQ:TXG) Price Target to $50.00Canaccord Genuity Group dropped their price target on 10x Genomics from $65.00 to $50.00 and set a "buy" rating on the stock in a research report on Monday.April 29, 2024 | finance.yahoo.comThe Zacks Analyst Blog Highlights 10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorpApril 25, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Sets New 52-Week Low at $26.4810x Genomics (NASDAQ:TXG) Reaches New 52-Week Low at $26.48April 23, 2024 | marketbeat.com10x Genomics (TXG) to Release Earnings on Tuesday10x Genomics (NASDAQ:TXG) will be releasing earnings after the market closes on Tuesday, April 30, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=583445)April 21, 2024 | nasdaq.comFirst Week of TXG June 21st Options TradingApril 18, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Shares Gap Down Following Analyst Downgrade10x Genomics (NASDAQ:TXG) Shares Gap Down Following Analyst DowngradeApril 17, 2024 | finance.yahoo.com10x Genomics, Inc. (TXG)April 16, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Trading Down 5.9%10x Genomics (NASDAQ:TXG) Trading Down 5.9%April 16, 2024 | marketbeat.com10x Genomics, Inc. (NASDAQ:TXG) Shares Bought by Sumitomo Mitsui Trust Holdings Inc.Sumitomo Mitsui Trust Holdings Inc. grew its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 32.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,283,530 shares of the company's stock after purchasing anApril 15, 2024 | marketbeat.comSVB Wealth LLC Has $80.95 Million Position in 10x Genomics, Inc. (NASDAQ:TXG)SVB Wealth LLC lifted its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 92.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,446,552 shares of the company's stock after acquiriApril 15, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Hits New 52-Week Low at $33.4710x Genomics (NASDAQ:TXG) Sets New 52-Week Low at $33.47April 11, 2024 | investing.comCathie Wood's ARK focuses on Teladoc and 10X Genomics stockApril 10, 2024 | finance.yahoo.com10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024 Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Executive Order To Wipe Out Your Bank Accounts (Ad)Don't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast. Click Here To Get Your FREE Guide Now! TXG Media Mentions By Week TXG Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TXG News Sentiment▼0.850.76▲Average Medical News Sentiment TXG News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TXG Articles This Week▼54▲TXG Articles Average Week Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bruker News Bio-Rad Laboratories News Bio-Rad Laboratories News Olink Holding AB (publ) News Standard BioTools News Cytek Biosciences News Quanterix News Pacific Biosciences of California News EyePoint Pharmaceuticals News Nautilus Biotechnology News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TXG) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored